UBS O'Connor’s TCV Acquisition Corp. Class A Ordinary Shares TCVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-236,972
Closed -$2.43M 737
2023
Q1
$2.43M Buy
+236,972
New +$2.41M 0.06% 255
2022
Q4
Sell
-239,291
Closed -$2.35M 671
2022
Q3
$2.35M Sell
239,291
-23,955
-9% -$235K 0.03% 558
2022
Q2
$2.57M Buy
+263,246
New +$2.57M 0.03% 551
2022
Q1
Sell
-258,607
Closed -$2.55M 530
2021
Q4
$2.55M Buy
258,607
+6,925
+3% +$68.3K 0.02% 462
2021
Q3
$2.47M Buy
251,682
+210,823
+516% +$2.08M 0.02% 473
2021
Q2
$405K Buy
+40,859
New +$414K ﹤0.01% 641

UBS O'Connor's TCVA Position: Q2 2023 in Review

UBS O'Connor sold out of TCV Acquisition Corp. Class A Ordinary Shares (TCVA) in Q2 2023, closing a stake of 236,972 shares — an estimated $2.43M sold.

UBS O'Connor first reported a position in TCVA in Q2 2021 and held it in 6 quarters. The position peaked at $2.57M in Q2 2022. 0 funds tracked by Wall St. Rank hold TCVA as of Q2 2023.

  • UBS O'Connor reported no remaining TCV Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • UBS O'Connor sold 236,972 TCV Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $2.43M.
  • UBS O'Connor first reported a position in TCV Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
  • UBS O'Connor's TCV Acquisition Corp. Class A Ordinary Shares position peaked at $2.57M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held TCV Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.